Equities researchers at StockNews.com started coverage on shares of Check-Cap (NASDAQ:CHEK – Get Free Report) in a research note issued on Sunday. The brokerage set a “sell” rating on the medical research company’s stock.
Check-Cap Stock Down 2.3 %
Shares of NASDAQ CHEK opened at $1.69 on Friday. The company has a market cap of $9.89 million, a P/E ratio of -0.56 and a beta of 0.39. Check-Cap has a 52 week low of $1.64 and a 52 week high of $4.63. The business has a 50-day simple moving average of $1.91 and a two-hundred day simple moving average of $2.11.
About Check-Cap
Featured Stories
- Five stocks we like better than Check-Cap
- How to Invest in Blue Chip Stocks
- Take Advantage of Village Farms Stock as Cannabis Market Evolves
- Stock Analyst Ratings and Canadian Analyst Ratings
- MarketBeat Week in Review – 9/16 – 9/20
- What Do S&P 500 Stocks Tell Investors About the Market?
- Don’t Miss These 3 Retail Stocks for Fall Gains
Receive News & Ratings for Check-Cap Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Check-Cap and related companies with MarketBeat.com's FREE daily email newsletter.